Collective Family Office’s Boston Scientific BSX Stock Holding History

Collective Family Office’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,148	Closed	-$231K	–	162
2025 Q2	$231K	Sell	2,148 -38	-2%	-$3.85K	0.06%	150
2025 Q1	$221K	Sell	2,186 -154	-7%	-$15.5K	0.06%	151
2024 Q4	$209K	Buy	+2,340	New	+$206K	0.06%	156
2022 Q3	–	Sell	-8,467	Closed	-$316K	–	172
2022 Q2	$316K	Sell	8,467 -160	-2%	-$6.51K	0.14%	142
2022 Q1	$382K	Sell	8,627 -20	-0.2%	-$867	0.15%	137
2021 Q4	$367K	Sell	8,647 -1,000	-10%	-$42K	0.14%	134
2021 Q3	$419K	Sell	9,647 -1,338	-12%	-$59.2K	0.18%	115
2021 Q2	$470K	Hold	10,985	–	–	0.2%	110
2021 Q1	$425K	Buy	10,985 +1,310	+14%	+$49.6K	0.21%	117
2020 Q4	$348K	Buy	+9,675	New	+$349K	0.19%	119

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Collective Family Office's BSX Position: Q3 2025 in Review

Collective Family Office sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 2,148 shares — an estimated $231K sold.

Collective Family Office first reported a position in BSX in Q4 2020 and held it in 10 quarters. The position peaked at $470K in Q2 2021. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

Collective Family Office reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
Collective Family Office sold 2,148 Boston Scientific shares in Q3 2025, an estimated $231K.
Collective Family Office first reported a position in Boston Scientific in Q4 2020 and held it in 10 quarters.
Collective Family Office's Boston Scientific position peaked at $470K in Q2 2021.
1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Collective Family Office's 13F filing for Q3 2025, filed 6 Oct 2025.